WallStreetZenWallStreetZen

NASDAQ: CDNA
Caredx Inc Stock Forecast, Predictions & Price Target

Analyst price target for CDNA

Based on 1 analyst offering 12 month price targets for Caredx Inc.
Min Forecast
$10.00-16.74%
Avg Forecast
$10.00-16.74%
Max Forecast
$10.00-16.74%

Should I buy or sell CDNA stock?

Based on 1 analyst offering ratings for Caredx Inc.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CDNA stock forecasts and price targets.

CDNA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-09

1 of 1

Forecast return on equity

Is CDNA forecast to generate an efficient return?
Company
N/A
Industry
8.68%
Market
28.92%

Forecast return on assets

Is CDNA forecast to generate an efficient return on assets?
Company
N/A
Industry
3.37%

CDNA revenue forecast

What is CDNA's revenue in the next 2 years based on estimates from 3 analysts?
Avg 1 year Forecast
$259.3M-7.48%
Avg 2 year Forecast
$290.0M+3.44%
CDNA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CDNA revenue growth forecast

How is CDNA forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
-7.48%
Industry
2.65%
Market
37.91%
CDNA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CDNA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CDNA vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
CDNA$12.01$10.00-16.74%Strong Buy
FLGT$23.24$31.50+35.54%Hold
CSTL$19.94$30.00+50.45%Strong Buy
OPK$0.99$2.25+126.59%Buy
SERA$9.34N/AN/A

Caredx Stock Forecast FAQ

Is Caredx Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: CDNA) stock is to Strong Buy CDNA stock.

Out of 1 analyst, 1 (100%) are recommending CDNA as a Strong Buy, 0 (0%) are recommending CDNA as a Buy, 0 (0%) are recommending CDNA as a Hold, 0 (0%) are recommending CDNA as a Sell, and 0 (0%) are recommending CDNA as a Strong Sell.

If you're new to stock investing, here's how to buy Caredx stock.

What is CDNA's revenue growth forecast for 2024-2025?

(NASDAQ: CDNA) Caredx's forecast annual revenue growth rate of -7.48% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 2.65%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 37.91%.

Caredx's revenue in 2024 is $280,324,000.On average, 3 Wall Street analysts forecast CDNA's revenue for 2024 to be $13,428,656,383, with the lowest CDNA revenue forecast at $13,300,349,203, and the highest CDNA revenue forecast at $13,497,418,262.

In 2025, CDNA is forecast to generate $15,013,752,308 in revenue, with the lowest revenue forecast at $15,013,752,308 and the highest revenue forecast at $15,013,752,308.

What is CDNA's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: CDNA) forecast ROA is N/A, which is lower than the forecast US Diagnostics & Research industry average of 3.37%.

What is CDNA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year CDNA price target, the average CDNA price target is $10.00, with the highest CDNA stock price forecast at $10.00 and the lowest CDNA stock price forecast at $10.00.

The Wall Street analyst predicted that Caredx's share price could fall to $10.00 by Nov 9, 2024. The average Caredx stock price prediction forecasts a potential downside of 16.74% from the current CDNA share price of $12.01.

What is CDNA's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: CDNA) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.